Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe.
Allosteric Site
Animals
Benzamides
/ chemical synthesis
Cell Line, Tumor
Discoidin Domain Receptor 1
/ chemistry
Discoidin Domain Receptor 2
/ chemistry
Dogs
HEK293 Cells
Humans
Madin Darby Canine Kidney Cells
Microsomes, Liver
/ metabolism
Protein Binding
Sulfonamides
/ chemical synthesis
p38 Mitogen-Activated Protein Kinases
/ chemistry
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
23 09 2021
23 09 2021
Historique:
pubmed:
11
9
2021
medline:
15
12
2021
entrez:
10
9
2021
Statut:
ppublish
Résumé
Discoidin domain receptors 1 and 2 (DDR1/2) play a central role in fibrotic disorders, such as renal and pulmonary fibrosis, atherosclerosis, and various forms of cancer. Potent and selective inhibitors, so-called chemical probe compounds, have been developed to study DDR1/2 kinase signaling. However, these inhibitors showed undesired activity on other kinases such as the tyrosine protein kinase receptor TIE or tropomyosin receptor kinases, which are related to angiogenesis and neuronal toxicity. In this study, we optimized our recently published p38 mitogen-activated protein kinase inhibitor
Identifiants
pubmed: 34506142
doi: 10.1021/acs.jmedchem.1c00868
doi:
Substances chimiques
Benzamides
0
Sulfonamides
0
DDR1 protein, human
EC 2.7.10.1
DDR2 protein, human
EC 2.7.10.1
Discoidin Domain Receptor 1
EC 2.7.10.1
Discoidin Domain Receptor 2
EC 2.7.10.1
p38 Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13451-13474Subventions
Organisme : Wellcome Trust
ID : 106169/ZZ14/Z
Pays : United Kingdom